+ ESC Handbook of Preventive Cardiology. + ESC Textbook of Cardiovascular Development. + ESC Textbook of Cardiovascular Medicine. + ESC Textbook of Intensive and Acute Cardiovascular Care. + ESC Textb
| 2025ȱժҪ һҪʾ 1ȱժҪȱȫģΪȫ˽Ȿ˾ľӪɹ״δչ滮ͶӦwww.sse.com.cnվϸĶȱȫġ 2شʾ˾ڱϸ˹˾ھӪпٵĸַռӦԴʩڡ֮ءֵIJͶעͶʷա 3˾»ἰ¡Ա֤ȱݵʵԡȷԡԣټءԳش©еķΡ 4˾ȫ嶭³ϯ»顣 5ŻʦͨϻΪ˾˱ޱƱ档 6˾ʱδӯδʵӯ ǡ̷ 7»ͨıԤתɱԤ˾2026324ٿ춭»ʮλ飬ͨŵҽƿѧɷ˾ڹ˾2025䷽鰸»Ϊ2025ȣܺϲھĸ˾ɶľΪ
Cordis的两项研究成果意味着：当下最新技术的药物球囊介入术已经具备取代传统支架植入的能力，有望进一步拓展“介入无植入”的临床边界。 其实在过去几年，药物
赛诺医疗科学技术股份有限公司2025 年年度报告摘要 公司代码：688108 公司简称：赛诺医疗 赛诺医疗科学技术股份有限公司 2025 年年度报告摘要 赛诺医疗科学技术股份有限公司2025 年���度报告摘要 第一节重要提示 1、本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展 规划，投资者应当到www.sse.com.cn 网站仔细阅读年度报告全文。 2、重大风险
In this population-based study, new-onset atrial fibrillation was present in roughly 50% of hospitalizations for transcatheter aortic valve implantation and
* Village Doctor–Led Telemedicine for Rural Patients Aged 75 Years and Older With AF: A Prespecified Secondary Analysis of the MIRACLE-AF TrialJAMA Network Open Research March 12, 2026 This prespeci
This multicenter registry study evaluates the clinical outcomes and changes in left ventricular ejection fraction after transcatheter aortic
This cohort study evaluates the association between Centers for Medicare & Medicaid Services transcatheter aortic valve replacement (TAVR)
Post-TAVR, the LVOT should be more circular, but in the entry region to the prosthesis, there is an abrupt acceleration of flow across a short
Herein, we focus on recommendations for perioperative management of medical therapies related to cardiovascular disease, including statins,
This Special Communication discusses the potential of the Ziltivekimab Cardiovascular Outcomes Trial (ZEUS) to provide a fully novel approach for prevention of
This interrupted time-series study investigates the clinical and health system–level implications of changing high-sensitivity cardiac troponin assays in
Explore the latest advances in PCI and device therapy, treatment of myocardial infarction, dyslipidemia, heart failure, afib & rhythm
Latest Issue. Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults. Original Investigation | February 4, 2026.
This study evaluates the cost-effectiveness of semaglutide for secondary prevention of cardiovascular disease and potential effect on US health care spending.
... aortic valve implantation (TAVI), thoracic and abdominal endovascular aneurysm repair (TEVAR and EVAR), and the use of a cardiac assist device (
To address these hurdles, the Allia IGS 7 system has been deployed as an addition to a hybrid operating room (OR), which Suckow describes as enhancing procedural accuracy and safety by reducing radiat
# Interventional News Interventional News. ### Interventional News Issue 101—March 2026. ### Gerry O’Sullivan. ### SHERPA research consortium initiates seven clinical trials for AI-based assistive tec
突发下肢缺血：瘤腔内血栓脱落，堵塞下肢动脉，会导致单侧腿部突然发凉、麻木、疼痛、肤色苍白，行走无力，这是紧急情况。
擅长: 急性下肢深静脉血栓外科治疗和全程管理：针对不同程度和原因的急性深静脉血栓，提供系统性解决方案慢性下肢深静脉血栓的腔内治疗和外科手术：改善困扰患者多年的深
2022年3月，母胎医学会(SMFM)发布了妊娠期心脏病患者的抗凝治疗指南。主要目的是为妊娠期常见心脏病（包括机械性心脏瓣膜病、房颤、收缩性心衰以及先天性心脏病）患者的抗凝
## 中国心房颤动管理：2025最新指南推荐，速览！. 2025 年 8 月 6 日，《中国心房颤动管理指南（2025）》正式网络首发。该《指南》在全面吸收国内外房颤相关指南 / 共识的核心要点以及近年来房颤基础与临床研究的前沿成果基础上，由中华医学会心电生理和起搏分会、中国医师协会心律学专业委员会和房颤中心专家委员会组织 67 名专家，对《心房颤动：目前的认识和治疗建议（2021）》进行了系统修
⑧ 就预防卒中而言，抗血小板及抗凝药物不能联合使用。合并冠心病及血管性疾病时，抗血小板联合抗凝药物的使用时间不得超过12个月，以减少出血的发生。 ⑨ 既往指导意见是抗凝
# 经导管主动脉瓣置换术市场细分及2034年增长情况. **历史数据 : 2021-2024 | 基准年 : 2025 | 预测期 : 2026-2034**. ## 经导管二尖瓣置换术市场规模及预测（2021-2034 年）、全球及区域份额、趋势和增长机会分析报告涵盖范围：按产品（机械瓣膜、生物瓣膜）；适应症（二尖瓣狭窄、二尖瓣脱垂、二尖瓣反流）；以及地域（北美、欧洲、亚
> 本次会议将汇聚3000余名国际心血管专家，围绕瓣膜与结构性心脏病、血管内治疗、技术创新及动脉粥样硬化等主题展开深入交流，28项最新临床研究/科学全景展现当前领域内最新进展，为未来发展指明方向。. 2026年美国心血管研究技术大会（CRT 2026）将于3月7日至10日在美国华盛顿举行。作为全球介入心脏病学领域的权威会议之一，CRT自1997年由克利夫兰医学中心及JACC等机构联合创办以来，始终
首页 » Media » 行业新知 » 上海医疗器械展览会|创新技术，心脏瓣膜介入技术. # 上海医疗器械展览会|创新技术，心脏瓣膜介入技术. 据《中国心血管健康与疾病报告2023》的信息，2022年度，全国共收治瓣膜性心脏病患者188.2万人次。其中，二尖瓣疾病患者数量最多，达到98.0万人次，占比高达45.4%；随后依次为三尖瓣疾病（28.5%）、主动脉瓣疾病（24.3%）与肺动脉瓣疾病（1.
Endovascular treatment of isolated abdominal aortic dissection and postoperative aortic remodeling ［ J ］ . Endovascular approach in isolated abdominal aortic dissections ［ J ］ . Endovascular treatment
选择腔内治疗的原因：（1）夹层原发破口位于升主动脉中段，距冠脉开口及弓上分支开口尚有距离，能提供足够的支架锚定区；（2）主动脉瓣未累及；（3）除升主动脉破口外
最新一期《美国心脏病学会杂志》（JACC）发表了第二军医大学长海医院血管外科教授景在平领衔的“升主动脉夹层腔内微创治疗疗效评估”研究成果。
心血管会议频道收录2016年心内科会议500场，包括心血管疾病学术会议、卫生部、全国全军心血管学习班、心电图培训学习班。
“全心计划”——心血管慢病全程管理. 2025年07月24日-2026年06月30日. 北京北京 ; 2026四川省心房颤动专病建设项目总结大会暨学术交流会（测试）. 2025年11月29日-2026年12月27日.
最新关注 医疗关注 医院活动 学科建设 健康患教 先进人物 医院文化 爱心公益 国考成绩. # 郑州大学第五附属医院心外科顺利为一位高龄老人实施「经心尖途径主动脉瓣置换术（TAVR）」. https://img1.dxycdn.com/p/s126/2026/0105/756/0407080557121108002.png. ### 郑州大学第五附属医院. 众所周知，心脏是人体最重要的器官之一，
July 9 - 12, 2026 ... SCCT2026 is the premier global meeting dedicated to cardiovascular CT, bringing together physicians, trainees, technologists and healthcare
DVT indicates deep vein thrombosis; and PE, pulmonary embolism. Diagnostic Testing. Recommendations for Diagnostic Testing Referenced studies that support
American Heart Association - Professional Heart Daily. X formerly known as Twitter. # 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease. Runner sitting
+ Congenital Heart Disease and Pediatric Cardiology. + Invasive Cardiovascular Angiography and Intervention. - ACC Anywhere: The Cardiology Video Library. - CardioSource Plus for Institutions and Prac
American Heart Association - Professional Heart Daily. X formerly known as Twitter. # Top Things to Know: 2026 Clinical Performance and Quality Measures for Patients With PAD. 2026 ACC/AHA Clinical Pe
## Eyebrow Menu. # Endovascular Aortic Repair. Endovascular aortic repair (EVAR) in a transcatheter method to repair abdominal aortic aneurysms (AAA) and thoracic endovascular aortic aneurysm repair (
Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection ... 2026 Elsevier B.V., its licensors
LINC 2026 Insights: Acute Aortic Dissection with Abdominal Aortic Occlusion - Endovascular ... IVL Pre-EVAR/TEVAR Tutorial, Chapter 1: Challenges
PASCAL vs MitraClip for Mitral Valve Transcatheter Edge-to-Edge Repair: A Single-Center Real-World Experience. JACC Cardiovasc Interv. 2022
The device is currently approved in the United States for patients with symptomatic primary (degenerative) MR who are at prohibitive risk for surgery, and
We present state-of-the-art and current evidence for both methods assumed to change the paradigm of treatment of valvular heart failure in the future.
专长：擅长血管外科常见疾病的诊治，如下肢动脉硬化闭塞症，颈动脉狭窄，锁骨下动脉狭窄，下肢深静脉血栓形成，下肢静脉曲张，腹主动脉瘤，主动脉夹层的腔内介入及外科手术治疗。. | 医生 | 时段 | 星期日 2026-04-05 | 星期一 2026-04-06 | 星期二 2026-04-07 | 星期三 2026-04-08 | 星期四 2026-04-09 | 星期五 2026-04-10 | 星
点击查看全文
点击查看全文
# SCC 2026丨“岭南心血管疾病大查房：指南与实践”专场成功举办：群英聚首话“心”疾，学术共进促提升. 2026年**3月21日**，第27届南方心血管病学术会议（SCC 2026）期间，备受关注的**“岭南心血管疾病大查房：指南与实践”**专场于广州成功举办。国内心血管领域权威专家齐聚一堂，围绕6例极具代表性的心血管典型病例展开深度剖析，并结合循证依据与自身丰富临床经验，对不同诊疗场景中的
这场承载无数心血与梦想的学术盛会，以“传承、创新、合作、共赢”为旗帜，再次汇聚全球心血管领域的智慧之光，在春意盎然的羊城，开启新一年的学术征程。
# 会议预告｜3.20-3.22，SCC 2026 · 泰尔茂学术专场邀您共探前沿技术，共话临床新发展！. 2026年3月19日，**第27届南方心血管病学术会议（The 27th South Congress of Cardiology，SCC 2026）**于广州白云国际会议中心国际会堂盛大召开。. 在这场心血管人的春日集会中，泰尔茂将携**「CTO-PCI 慢性完全闭塞病变的处理技术专题」*
中华医学会心血管病学分会. 中华医学会学术会务部. 2026年3月. 基本信息. 会议时间：2026年4月16日-19日. 开幕式和主题讲座：2026年4月18日. 会议地点：北京
#广州第27届南方心血管病学术会议#在第27届南方心血管病学术大会上，张运院士发布了通心络胶囊治疗易损斑块的多中心研究结果。研究表明，在他汀标准治疗基础上加用通心络，可显著增厚冠脉斑块纤维帽，缩小脂质核心，有效稳定“薄皮大馅”的易损斑块，降低心血管事件风险。该成果发表于国际权威期刊，为 . #中国学者攻破心血管易损斑块难题##为什么血管有斑块的年轻人越来越多了#【通心络稳定冠脉易损斑块新证据发布
赛诺医疗科学技术股份有限公司2025 年年度报告摘要 公司代码：688108 公司简称：赛诺医疗 赛诺医疗科学技术股份有限公司 2025 年年度报告摘要 赛诺医疗科学技术股份有限公司2025 年年度报告摘要 第一节重要提示 1、本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展 规划，投资者应当到www.sse.com.cn 网站仔细阅读年度报告全文。 2、重大风险提示
... 药物支架（HT Supreme）凭借优异数据正快速收复市场。核心优势在于对冠脉领域的专注与持续的高强度研发。2026年，其重磅产品——颅内药物球囊的获批与
当保守治疗无效，反复出现症状的PTS，或者年轻群体患有PTS时，才考虑外科及血管内介入治疗，皮肤的改变常成为外科干预的主要原因。目前，主要外科干预方法是腔内支架成形术。
擅长复杂主动脉瘤及主动脉夹层的精准微创腔内治疗，并在下肢深静脉血栓、下肢动脉疾病、颈动脉疾病及其他复杂血管疾病的综合诊治方面具有丰富经验。
近日，首都医科大学附属北京潞河医院血管外科成功完成一例复杂静脉血栓栓塞症的微创介入治疗，手术团队通过急诊肺动脉介入溶栓联合髂股静脉血栓减容及髂
... 血管外科、浙江大学附属邵逸夫医院血管外科业务学习。擅长以手术及介入微创方法治疗血管外科各种动脉、静脉疾病，如动脉夹层、动脉瘤、下肢动脉硬化性
深静脉血栓是血管外科常见的急重症，尤其当血栓累及下肢深静脉主干时，易引发血栓后综合征，严重影响患者生活质量，甚至危及生命。此次重症下肢深静脉血栓患者
心房颤动诊断和治疗最新指南，一文读懂 · ≥2分（男性）或≥3分（女性）需抗凝；. 1分（男性）或2分（女性）建议个体化评估，也应当考虑使用OAC。 · 一线治疗：有症状的阵发性房颤、药物
当前位置：首页> 新闻中心 >最新专家共识发布——高龄心房颤动患者抗凝治疗中国专家共识(2024). #### 最新专家共识发布——高龄心房颤动患者抗凝治疗中国专家共识(2024). 1.1 高龄心房颤动流行病学特点 心房颤动患病率随增龄而显著增加，≥80岁高龄人群心房颤动患病率显著上升，80～84岁人群患病率为6.52%，95岁以上高达8.18%。在≥80岁高龄心房颤动患者中，男女比例约为1.2
如何打破“术后易复发、药效难兼顾、症状有残余” 的临床困境，突破碎片化诊疗的局限，平衡抗凝用药的获益与出血风险，延缓甚至逆转房颤带来的心脏病理损伤，已
# 中国心房颤动管理指南（2025）更新要点及解读. 《中国心房颤动管理指南（2025）》由中华医学会心电生理和起搏分会和中国医师协会心律学专业委员会组织心房颤动（房颤）领域专家，在吸收国内外房颤相关指南/共识重点内容及近年来有关房颤基础与临床研究成果的基础上，对《心房颤动：目前的认识和治疗建议（2021）》升级而成。. 以房颤发作的时程予以分类，包括首诊房颤、阵发性房颤、持续性房颤、长程持续性房
『附一医讯』TAVR让心脏重获“强动力”！柴大军教授团队利用经导管主动脉置入术（TAVR）成功治疗一例高难度主动脉瓣狭窄伴关闭不全.
刘煜昊主任介绍，TAVR（经导管主动脉瓣置换）是国际领先的技术，能够给危重主动脉瓣患者带来手术机会。多种型号TAVR瓣膜全面纳入医保报销后，将会有很多患者因此受益。
DOI: 10.12677/acm.2026.162404 经导管心脏瓣膜置换治疗的发展现状 郭丹麒1,2，刘子由1,2,3* 1赣南医科大学第一临床医学院，江西 赣州 2赣南医科大学第一附属医院心胸外科，江西 赣州 3赣南医科大学心脑血管疾病防治教育部重点实验室临床分部，江西 赣州 收稿日期：2025年12月27日；录用日期：2026年1月21日；发布日期：2026年1月30日 摘 要 心脏瓣膜
PARTNER 2研究10年随访结果表明：对于中度手术风险的症状性重度主动脉瓣狭窄患者，SAPIEN 3瓣膜TAVR的疗效不劣于外科手术治疗，TAVR的10年瓣膜再干预率为3.0%
主动脉大支架手术难度大，风险高，该例手术的成功开展，是我市首例主动脉覆膜支架腔内隔绝术手术，标志着我院在大血管领域又一重大医疗技术突破，填补了高邮
以体外循环为基础的开胸大手术一直以来是升主动脉夹层的标准治疗方法，但升主动脉夹层开放手术死亡率可达26%，而28%的升主动脉夹层则由于各种原因被认为不
目前,主动脉夹层的腔内修复治疗一般不对夹层远段内膜破口进行处理。但近期研究和随访发现,处理主动脉夹层远段破口,对主动脉夹层腔内修复术后促进主动脉真腔重塑和加快假腔
覆膜支架腔内隔绝术是将支架-人造血管复合体导入腹主动脉，膨胀后将腹主动脉瘤与血管腔隔绝，促使其逐渐机化、缩小，从而消除瘤体破裂、出血的隐患，达到治疗
夹层动脉瘤是AD主要的远期并发症，治疗的主要目的在于尽可能促进假腔内血栓形成，预防假腔瘤样扩张所致的破裂。目前慢性期夹层较为公认的手术指征为夹层动脉
2026湖南省复杂冠脉介入研讨会暨2026湖南省腔内影像学交流会暨湖南省复杂冠脉介入俱乐部（2026 长沙站）. 2026年03月28日-2026年03月29日. 湖南长沙.
异种移植和心脏异种移植领域取得了长足的进步，本文回顾了该领域的现状，并概述了推动该领域向前发展的建议。 评论. 临床指南，点亮医生进阶之路.
... 心血管 ... 南方会5大疾病最新诊疗进展报告. 在南方会上，多位知名专家介绍了介绍了国内心血管病诊疗研究的最新进展，病结合指南和自己的临床经验给出诊疗建议。 ... 2026
主要可等心血管领域的临床及实验研究结果、最新进展、专家观点、读者来信及相关讨论等。主要栏目包括：原始研究、基本概念、最新进展、影像品读、述评及读者.
中国心血管病相关专家小组（统称）. 指南#心血管内科. 3天前. 2026 法国共识声明：成人血脂异常的管理. 法国内分泌学会. 指南#心血管内科. 3天前. 2025 ACC专家共识决策
主动脉瓣狭窄治疗新进展：经导管主动脉瓣置换术（TAVR）与外科主动脉瓣置换术（SAVR）在治疗高风险主动脉瓣狭窄患者上具有相似的死亡率。
... 主动脉瓣经导管置入到主动脉根部，替代原有主动脉瓣，在功能上完成主动脉瓣的置换，恢复瓣膜功能。 TAVI 技术的开展让高龄、合并症多、心功能差、不能耐受开胸体外循环
Evolut Pro 是TAVR 瓣膜的一种，也是目前最先进全球使用量最多的一款自膨式人工主动脉瓣膜，其特点是在保证瓣膜整体顺应性的同时，强化了瓣架径向支撑力，瓣膜
此次全国首批开展TaurusTrio 系统下的TAVR 手术，彰显了医院在心脏瓣膜微创介入治疗领域领先的技术实力，为主动脉瓣反流患者开启了微创化、精准化的治疗新
主动脉瓣是心脏瓣膜的一种，又称「心门」，其规律性开合是心脏正常运行的 ... EBMT 2026 丨高博专家团队携20 项研究成果亮相，创新实践守护血液
## Specialty Menu Navigation. ## Clinical. ## Heart Failure. ## Heart Rhythm. ## Top User Menu. ## Main navigation. # ACC 2026 Day 1 Wrap-Up. David Cohen and Sunil Rao discuss today's late breakers, i
# Join Us at TCT® 2026. # Where Pioneers Unite To Shape the Future of Interventional Cardiology — Be There! REGISTER NOW TO SAVE SUBMIT YOUR SCIENCE. # Innovation. # TCT® — The Global Forum for Interv
We rounded up 11 cardiology conferences worth tracking in 2026, with verified dates and locations. ### “Every keystroke saved, is time saved, which means I can do my job longer and see more children.”
This British Cardiovascular Intervention Society position statement describes the diagnosis, indications and procedure for PFO closure. Transcatheter patent foramen ovale (PFO) closure has been undert
... 2026 Clinical Practice Guidelines for the Prevention and Treatment of New-Onset Postoperative AF After Cardiac Surgery. Feature Interview from EP Lab Digest.
The device is indicated for percutaneous transcatheter closure of a PFO to reduce the risk of recurrent ischemic stroke in individuals (predominantly between ages 18 to 60 years of age) who have had a
Following existing guidelines, oral anticoagulation should be started in most patients with AF after PFO closure. However, the real necessity of
AF Symposium 2026 - Pulsed field ablation in atrial fibrillation: Will it Redefine AF Ablation Strategies? Arrhythmia Academy board member
The ACC article presents an overview of current recommendations to create a consensus report for adults with both diabetes and PAD. In patients not at increased risk of PAD and without history or phys
AHA Guideline and Statements Hub content for 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease.
American Heart Association - Professional Heart Daily. X formerly known as Twitter. # Top Things to Know: 2026 Clinical Performance and Quality Measures for Patients With PAD. 2026 ACC/AHA Clinical Pe
To date, open surgery, endovascular treatment, and hybrid treatments have been used to treat PDAAs.6,7,8,9 Open surgery still requires high technical demands and is also associated with significant tr
Patients with thoracic aortic disease are recommended to be fully informed about all treatment options (medical management, endovascular repair,
There are four FDA approved TEVAR devices in the United States for the treatment of the thoracic dissections, namely Gore, Medtronic, Cook, and Terumo.
TEVAR can be safely performed in patients with CTDs but carries a significant risk of short- to intermediate-term aortic-related complications.
Endovascular repair of chronic aortic dissections is often complicated by a compressed true lumen (TL) and difficult access to branch vessels.
Using electrosurgical disruption of the chronic dissection septum to expand true lumen channel and improve stent graft outcomes in aortic dissection. By Steven
M-TEER with the fourth-generation M-TEER device was safe and effective at 1 year, with durable reductions in MR severity to ≤1+ in more than 90% of patients.
In a national registry study, successful repair was associated with lower mortality and heart failure hospitalization rates. Transcatheter mitral valve
This study sought to determine whether TAVR for moderate AS provides clinical benefit in patients with HFrEF on top of GDMT.
Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System. January 28, 2023. [ MEDLINE Abstract ].
Save the Date For ACC.27-WCC. Thousands of cardiovascular professionals from around the globe came together to connect, learn and be inspired at ACC.26.
Why It Stands Out in 2026: AHA Scientific Sessions is the second major pillar of the U.S. cardiovascular conference calendar alongside ACC, and
Organised by the Association for Acute CardioVascular Care (ACVC), the congress unites professionals passionate about acute and critical cardiovascular care.
ESC Congress 2026. 28 - 31 August / Munich - Germany ... Unlimited access to ESC Acute CardioVascular Care congress resources on ESC 365.
Copyright © 2026 United Healthcare Services, Inc. Click Anywhere in the Header to Return to the Main Table of Contents Cardiovascular and Radiology Imaging Guidelines V1.0.2026 Benefits, Coverage Poli
Objectives: Cancer is typically associated with venous thrombosis but its impact on patients undergoing peripheral vascular interventions (PVI) for concomitant
Peripheral vascular disease (PVD) involves damage to or blockage in the blood vessels distant from your heart—the peripheral arteries and veins. Your peripheral arteries and veins carry blood to and f
In the present study, we aimed to quantify the incidence of VTE after infrainguinal percutaneous endovascular interventions for peripheral arterial disease (PAD)
MyMichigan offers MitraClip™ therapy, a minimally invasive treatment for mitral valve regurgitation, helping patients avoid open heart surgery and improve
“This study provides, to our knowledge, the longest follow-up to date in patients undergoing transcatheter PFO closure after PFO-associated
PFO closure takes approximately two hours to complete and consists of a catheter and closure device being inserted through a vein, where the device will be
PFO closure is generally recommended for patients with a PFO who have had a stroke and no other obvious cause for the stroke. The decision to perform PFO
Patent Foramen Ovale (PFO) Closure — During PFO closure, your provider uses a catheter to implant a closure device into a hole in the wall between the upper
Cardiac Book Evaluation Copy 2026 CPT © 2025 American Medical Association All Rights Reserved © 2003-2026 ZHealth Publishing All Rights Reserved 162 C O D E S : PROCEDURE DESCRIPTION PROC CODE APC WOR
近年来，Stanford A型主动脉夹层（TAAD）的外科处理虽已取得显著进展，但初次修复后的残余弓部病变依然是临床难题。研究显示，约10%至23%的患者在首次
医生紧急安排主动脉CT检查，结果证实了最危险的诊断：主动脉夹层。 医院心脏血管外科陆华主任介绍，主动脉夹层分为Stanford A型和B型。A型夹层破口
主要涉及主题：(1)急性胸主动脉综合征；(2)慢性B型主动脉夹层；(3)胸降、胸腹主动脉瘤；(4)胸降动脉瘤、胸腹主动脉瘤破裂；(5)钝性胸主动脉损伤。 下载附件：. (
主动脉夹层是最凶险的血管疾病之一，死亡率可达70-90%。 而腔内微创治疗因避免了开胸、开腹和主动脉阻断，微创且快速有效，目前已成为主动脉夹层的主要治疗
近日，山东大学齐鲁第二医院心血管外科协同多学科团队成功为一名复杂胸腹主动脉夹层患者实施胸腹主动脉置换术。该手术的顺利完成，标志着齐鲁二院在复杂
此次手术成功解决了残余夹层带来的压迫和高血压难题，有效防止了潜在的致命性血管扩张风险，为患者真正解除了“后顾之忧”。
An international array of cardiovascular specialists showcased the field's latest imaging tools, devices and interventional procedures.
Key findings at 90 days included a 40% relative increase in valve intervention and 27% increase in MHT evaluations. Data suggested that white
In this video, Sammy Elmariah, MD, chief of Interventional Cardiology at UCSF, discusses the latest advances in treating aortic stenosis
Ongoing advances in technological design and operator experience have led to continued improvements in TAVR's safety and complication rates.
FDA-approved valve makes US debut | Reviewing CRT 2026 | First TAVR of its kind uses crushed stent | 20-year PFO closure data · Editor's Choice:
The 6-year results of the Evolut Low Risk trial show no difference in the primary composite endpoint between TAVR and surgery,
Our prespecified objective was to report the 6-year clinical outcomes of transcatheter aortic valve replacement (TAVR) vs surgery from the Evolut Low Risk
At one year post TAVR, among patients younger than 65 years, every five-year increase in age saw a 10% decrease in mortality (adjusted hazard
点击查看全文
点击查看全文
Milestonessinomed\_ynv81y2026-03-31T14:15:53+08:00. * 8月，赛诺神畅全球首款自膨式颅内药物涂层支架系统及球囊微导管获得美国FDA突破性医疗器械认定、AURALINE 一次性使用微导管获批上市、产品(APEX TRA SYSTEM® 桡动脉通路导引系统配合RAYLINE®微导管系统)助力非洲义诊，志愿医生在埃塞成功实施经桡入路颅内动脉瘤栓塞术；赛
点击查看全文
点击查看全文
This month: traffic noise causes CV stress, concerns about the USPSTF, "metabolic whiplash" from stopping GLP-1s, and more.
点击查看全文
点击查看全文
点击查看全文